Health Risk Assessment Practices in the U.S. Food and Drug Administration

By Gaylor D.W.   Axelrad J.A.   Brown R.P.   Cavagnaro J.A.   Cyr W.H.   Hulebak K.L.   Lorentzen R.J.   Miller M.A.   Mulligan L.T.   Schwetz B.A.  

Regulatory Toxicology and Pharmacology, Vol. 26, Iss. 3, 1997-12 ,pp. : 307-321

Academic Press

Access to resources Recommend Favorite

Mathematical Assessment of Properties of Precursor-Dependent Indirect Pharmacodynamic Response Models

By Hazra Anasuya   Krzyzanski Wojciech   Jusko William  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 33, Iss. 6, 2006-12 ,pp. : 683-717

Springer Publishing Company

Access to resources Recommend Favorite

Assessment of Drug Interactions Relevant to Pharmacodynamic Indirect Response Models

By Earp Justin   Krzyzanski Wojciech   Chakraborty Abhijit   Zamacona Miren K.   Jusko William J.  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 31, Iss. 5, 2004-10 ,pp. : 345-380

Springer Publishing Company

Access to resources Recommend Favorite

Alzheimer’s disease: transgenic mouse models and drug assessment

By Yu P.   Oberto G.  

Pharmacological Research, Vol. 42, Iss. 2, 2000-08 ,pp. : 107-114

Academic Press

Access to resources Recommend Favorite

In-Silico ADME Models: A General Assessment of their Utility in Drug Discovery Applications

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 4, 2011-02 ,pp. : 358-381

Bentham Science Publishers

Access to resources Recommend Favorite